LTS Lohmann Therapie-Systeme AG
Andernach, Germany
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (4)
○ EMA GMP
○ MHRA GMP
Quick Facts: LTS Lohmann Therapie-Systeme AG
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Andernach, Germany
- Modalities
- Transdermal Patches (TTS), Oral Thin Films (OTF), Microneedle Array Patches (MAP), Wearable/On-Body Drug Delivery Devices, Nasal Sprays (via Renaissance Lakewood acquisition), Sterile Dosage Forms
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About LTS Lohmann Therapie-Systeme AG
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesTransdermal Patches (TTS), Oral Thin Films (OTF), Microneedle Array Patches (MAP), Wearable/On-Body Drug Delivery Devices, Nasal Sprays (via Renaissance Lakewood acquisition), Sterile Dosage Forms
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press4 articles
Broad modality coverage (6 modalities)
Recent News 4 articles
LTS to Acquire Renaissance Lakewood - Contract Pharma
Simtra BioPharma Solutions Appoints Chief Commercial Officer - Contract Pharma
LTS – Your Partner for Innovative Solutions - Pharmaceutical Business review -
LTS, GRAM Enter Strategic Fill Finish Pact for Wearable Injectors - Contract Pharma
Frequently Asked Questions About LTS Lohmann Therapie-Systeme AG
What is LTS Lohmann Therapie-Systeme AG's CDMO Signal Score?
LTS Lohmann Therapie-Systeme AG has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating LTS Lohmann Therapie-Systeme AG for a manufacturing program?
Use the free AI matchmaker to compare LTS Lohmann Therapie-Systeme AG against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.